Ian Tully is a partner in the Corporate Practice in our Milan office.

    Dual-qualified in Italy and the UK, Ian’s practice focuses on mergers and acquisitions and corporate finance, often with a cross-border element. In addition to his heavy involvement in the energy sector, Ian has significant experience in the automotive, pharmaceutical and healthcare industries.

    Ian regularly advises clients on international commercial contracts, cross-border mergers and acquisitions, private equity and corporate finance transactions. He has particular experience in Italy and the UK, and has advised on many trans-European transactions. He is notable for his cultural sensitivity, practical approach and negotiation skills.

    Ian has represented a range of companies on joint ventures; share and asset purchase and sale transactions; corporate restructurings; debt and equity capital-raising transactions; corporate governance issues; partnership agreements; licensing and sales agreements; technical assistance agreements; research and development agreements; product supply and toll manufacturing agreements; and distribution and agency agreements.

    Many of Ian’s M&A transactions are in the pharmaceutical, medical device and wider healthcare industry – a sector in which he has built a reputation of significant industry expertise.

    Award Mouse thought multimedia interface book medal screen monitor
    • Advised a Japanese multinational in respect of its acquisition of an Italian software development company active in the healthcare sector.
    • Advised a German group active in the logistics sector on its strategic acquisition through its Italian subsidiary of 100% of an Italy-based multinational that provides international shipment services.
    • Advised one of the main wine and spirits companies worldwide on its acquisition of an Italian super-premium gin brand, with operations in 29 jurisdictions.
    • Advised a Miami-based ship interiors group on the sale of an Italian primary operator active in the field of naval refitting to an Italy-headquartered naval fitting multinational, owned by a private equity fund.
    • Advised a leading Italian postal, logistics and financial services group on its investment in a UK-based European asset management firm. 
    • Advised a global telecommunications group on the legal due diligence and drafting of the transaction documents in connection with the acquisition of a minority participation in an Italian company active in developing and marketing systems and products related to the logistics and automotive sectors.
    • Advised an Australian listed group on the sale of an Italian brake pad producer to a leading German automotive components and tyre group following its takeover by another German multinational group.
    • Advised a global oil and gas group on its acquisition of 49% of an Italian global leader in providing engineering and procurement services active in Europe, Africa, the Middle East and Asia.
    • Advised an Italian art and culture publishing house on its acquisition of an historic Italian publisher from a leading Italian publishing group.
    • Advised the purchaser and the MBO team on a management buyout transaction of an Italian publishing house in the context of a restructuring turnaround programme submitted for approval to the Italian courts and on an  investment by, and subsequent sale to, a private equity fund.
    • Advised an Italian company active in the nuclear medicine sector on its negotiations for a 12 million investment by an Italian government-controlled private equity fund.
    • Advised an Italian listed energy infrastructure group in relation to its acquisition of a major Italian gas distribution group and a leading gas storage group from an Italy-based oil and gas multinational and on its placement of shares on the Italian stock exchange to part-finance the purchases.
    • Advised a Norwegian industrial conglomerate on the Italian aspects of its 2.5 billion sale of a business to a Chinese group, including carrying out a vendor due diligence exercise.
    • Advised an Italian paint coatings group on its acquisition of the European powder-coating business of a Sweden-based group, a primary supplier of coat paint to a UK manufacturer of heavy industrial and agricultural vehicles.
    • Advised an Australian listed group on its €40 million purchase of a leading European producer of brake pads for the automotive industry from a UK-based private equity fund.
    • Advised a leading Italian energy group in connection with its purchase of a retail network of fuel stations located in southern Italy.
    • Advised a global chemicals group on the listing with a simultaneous public and institutional share offering of the majority of its shares in an Italian subsidiary, and subsequent sale of its remaining stake to a private equty fund.
    • Advised a US-headquartered private equity fund focused on the real estate sector on the purchase of a 5 star hotel in Rome, as part of a portfolio of 9 trophy hotels around Europe.
    • Advised a leading Italian energy group in relation to its joint venture with a leading global oil and gas player for the development of a 400 million re-gasification project in Italy.
    • Advised a leading Italian energy group on its £400 million sale of a Greek cement group to a UK-listed multinational.
    • Advised a Singapore-based and NASDAQ-listed logistics multinational on the sale of a French subsidiary to an Italian group.
    • Advised a UK group active in the industrial antifreeze sector of the transportation market on a strategic commercial joint venture for servicing European airports.
    • Advised a leading Italian design furnishings producer on its Abu Dhabi joint venture with a leading sovereign wealth fund.
    • Advised a European private equity fund specialised in the renewable energy sector in its sale of a wave energy power project.
    • Advised an Italian bank on a major outsourcing project involving the outsourcing of much of its IT infrastructure to a US-based service provider, including dealing with complex employee relations issues.
    • Advised a private equity fund on the acquisition of a   fashion apparel business across five jurisdictions from a UK-listed company, as well as in relation to a series of corporate transactions of its portfolio companies.
    • Advised a UK-based investment fund on its 94 million joint venture with a listed Italian property group, as well as on other real estate investments in Italy.
    • Advised a listed Italian company on its acquisition of a UK ticketing software provider group, a leader in the provision of ticketing services to London West End theatres.
    • Advised an Italian chemical company on its acquisition of a UK-based chemical group from a US-based multinational.
    • Advised a European private equity fund on a bid for the purchase of a global car component company with manufacturing plants across 12 jurisdictions, including conducting and coordinating a legal due diligence exercise.

    Healthcare Experience

    • Advised an Italy-headquartered pharmaceutical group on the acquisition of an Italian pharmaceutical group of companies specialised in the ophthalmic sector.
    • Advised a global pharmaceutical group on the sale of a 400-employee industrial plant to a Germany-based group and related supply and tolling agreements.
    • Advised a global pharmaceutical group on the sale of an Italian subsidiary to an Italian multinational, through a competitive auction process.
    • Advised an Italian pharmaceutical group on its US$34 million sale of a biotech subsidiary to a US-based NASDAQ-listed group.
    • Advised a company based in Switzerland active in the pharmaceutical, nutritional and cosmetic sectors on its purchase of an Italian pharmaceutical company.
    • Advised an Italy-headquartered pharmaceutical group on the transfer of business in the generic pharmaceuticals sector relating to drugs for stomachache treatment to a group specialised in generic pharmaceuticals.
    • Advised a French group active in the pharmaceutical sector on the acquisition of an Italian company active in IT services for the healthcare sector from an Italian IT services group.
    • Advised an Italian pharmaceutical company on the disposal of a 14% shareholding stake in a NASDAQ-listed biotech company, principally through two block trade transactions for an aggregate consideration of approximately US$50 million, following upon settlement of a contractual dispute contested before the LCIA.
    • Advised an Italy-headquartered pharmaceutical group on the sale of its ophthalmic business to a US multinational.

    Education

    • Northumbria University, Law Society Finals, 1990
    • Trinity College Dublin, LL.B., 1989

    Admissions

    • Milan, 2004
    • England and Wales, 1992

    Languages

    • Italian
    • English
    • French
    • Lawyer of the Year Pharmaceutical M&A, Legalcommunity Awards 2017
    • Recognised Lawyer, Chambers Global and Chambers Europe for Corporate/M&A

    {{insights.date}} {{insights.source}} {{insights.type}}
    {{blog.displayDate}}
    {{blog.title}} {{blog.source}}

    • Lawyer of the Year Pharmaceutical M&A, Legalcommunity Awards 2017
    • Recognised Lawyer, Chambers Global and Chambers European for Corporate/M&A

    • Advised an Italy-headquartered pharmaceutical group on the acquisition of an Italian pharmaceutical group of companies specialised in the ophthalmic sector.
    • Advised a global pharmaceutical group on the sale of a 400-employee industrial plant to a Germany-based group and related supply and tolling agreements.
    • Advised a global pharmaceutical group on the sale of an Italian subsidiary to an Italian multinational, through a competitive auction process.
    • Advised an Italian pharmaceutical group on its US$34 million sale of a biotech subsidiary to a US-based NASDAQ-listed group.
    • Advised a company based in Switzerland active in the pharmaceutical, nutritional and cosmetic sectors on its purchase of an Italian pharmaceutical company.
    • Advised an Italy-headquartered pharmaceutical group on the transfer of business in the generic pharmaceuticals sector relating to drugs for stomachache treatment to a group specialised in generic pharmaceuticals.
    • Advised a French group active in the pharmaceutical sector on the acquisition of an Italian company active in IT services for the healthcare sector from an Italian IT services group.
    • Advised an Italian pharmaceutical company on the disposal of a 14% shareholding stake in a NASDAQ-listed biotech company, principally through two block trade transactions for an aggregate consideration of approximately US$50 million, following upon settlement of a contractual dispute contested before the LCIA.
    • Advised an Italy-headquartered pharmaceutical group on the sale of its ophthalmic business to a US multinational.
    • Advised a Japanese multinational in respect of its acquisition of an Italian software development company active in the healthcare sector.

    Award Mouse thought multimedia interface book medal screen monitor